Ardelyx, Inc. (ARDX)
3.28
+0.01
(+0.31%)
USD |
NASDAQ |
Oct 09, 16:00
3.275
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Free Cash Flow : -17.92M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.92M |
| March 31, 2026 | -37.50M |
| December 31, 2025 | -43.98M |
| September 30, 2025 | -55.35M |
| June 30, 2025 | -55.19M |
| March 31, 2025 | -48.73M |
| December 31, 2024 | -45.82M |
| September 30, 2024 | -63.80M |
| June 30, 2024 | -85.82M |
| March 31, 2024 | -81.12M |
| December 31, 2023 | -90.06M |
| September 30, 2023 | -67.07M |
| June 30, 2023 | -70.84M |
| March 31, 2023 | -87.29M |
| December 31, 2022 | -70.10M |
| September 30, 2022 | -123.70M |
| June 30, 2022 | -133.31M |
| March 31, 2022 | -137.04M |
| December 31, 2021 | -154.42M |
| September 30, 2021 | -132.88M |
| June 30, 2021 | -117.78M |
| March 31, 2021 | -101.78M |
| December 31, 2020 | -81.76M |
| Date | Value |
|---|---|
| September 30, 2020 | -75.06M |
| June 30, 2020 | -75.86M |
| March 31, 2020 | -84.70M |
| December 31, 2019 | -76.81M |
| September 30, 2019 | -84.40M |
| June 30, 2019 | -90.66M |
| March 31, 2019 | -80.80M |
| December 31, 2018 | -70.58M |
| September 30, 2018 | -47.19M |
| June 30, 2018 | -39.66M |
| March 31, 2018 | -46.52M |
| December 31, 2017 | -67.54M |
| September 30, 2017 | -101.53M |
| June 30, 2017 | -108.51M |
| March 31, 2017 | -108.83M |
| December 31, 2016 | -97.40M |
| September 30, 2016 | -90.14M |
| June 30, 2016 | -76.18M |
| March 31, 2016 | -82.48M |
| December 31, 2015 | -75.29M |
| September 30, 2015 | -58.06M |
| June 30, 2015 | -51.35M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Capricor Therapeutics, Inc. | -129.78M |
| REGENXBIO, Inc. | -249.67M |
| Compass Therapeutics, Inc. | -56.38M |
| ARS Pharmaceuticals, Inc. | -196.60M |
| Sionna Therapeutics, Inc. | -76.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.399M |
| Cash from Investing (Quarterly) | 22.66M |
| Cash from Financing (Quarterly) | 49.72M |
| Free Cash Flow Per Share (Quarterly) | -0.0258 |
| Free Cash Flow to Equity (Quarterly) | -54.34M |
| Free Cash Flow to Firm (Quarterly) | -0.1468M |
| Free Cash Flow Yield | -2.23% |